Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

New trial data has cemented Club holding Eli Lilly's pole position in the highly competitive weight loss drug race.

Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. 

Scott Olson | Getty Images

New trial data has cemented Club holding Eli Lilly's pole position in the highly competitive obesity drug race.